GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Cryosite Ltd (ASX:CTE) » Definitions » Cash Flow for Lease Financing

Cryosite (ASX:CTE) Cash Flow for Lease Financing : A$0.00 Mil (TTM As of Dec. 2023)


View and export this data going back to 2002. Start your Free Trial

What is Cryosite Cash Flow for Lease Financing?

Cryosite's Cash Flow for Lease Financing for the six months ended in Dec. 2023 was A$0.00 Mil. Cryosite's Cash Flow for Lease Financing for the trailing twelve months (TTM) ended in Dec. 2023 was A$0.00 Mil.

Compared with last quarter (A$0.00 Mil in Jun. 2023 ), Cryosite's Cash Flow for Lease Financing remained the same in Dec. 2023 (A$0.00 Mil).

Cryosite Cash Flow for Lease Financing Historical Data

The historical data trend for Cryosite's Cash Flow for Lease Financing can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Cryosite Cash Flow for Lease Financing Chart

Cryosite Annual Data
Trend Jun14 Jun15 Jun16 Jun17 Jun18 Jun19 Jun20 Jun21 Jun22 Jun23
Cash Flow for Lease Financing
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - - -

Cryosite Semi-Annual Data
Jun14 Dec14 Jun15 Dec15 Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23
Cash Flow for Lease Financing Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Cryosite Cash Flow for Lease Financing Calculation

Cash Flow for Lease Financing is change in cash flow resulting from increase or decrease in lease financing.


Cash Flow for Lease Financing for the trailing twelve months (TTM) ended in Dec. 2023 adds up the semi-annually data reported by the company within the most recent 12 months, which was A$0.00 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Cryosite Cash Flow for Lease Financing Related Terms

Thank you for viewing the detailed overview of Cryosite's Cash Flow for Lease Financing provided by GuruFocus.com. Please click on the following links to see related term pages.

Cryosite (ASX:CTE) Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Cryosite Ltd (ASX:CTE) » Definitions » Cash Flow for Lease Financing
Comparable Companies
ASX:IIQ ASX:LDX ASX:BDX ASX:RHY ASX:GTG ASX:IBX ASX:MAP ASX:GSS TMO DHR IQV XSWX:LONN IDXX A MTD ICLR ILMN WAT SHSE:603259 LH
Traded in Other Exchanges
N/A
Address
13a Ferndell Street, South Granville, Sydney, NSW, AUS, 2142
Website
https://www.cryosite.com
Cryosite Ltd is engaged in the provision of supply chain logistics, management of pharmaceutical products used in clinical trials. The company's operating segment includes Cord Blood and Tissue Storage and Clinical Trials and Biological Services Logistics. It generates maximum revenue from the Clinical Trials and Biological Services Logistics segment. Clinical Trials and Biological Services Logistics segment provides specialist temperature-controlled storage, sourcing, labelling, status management, secondary packaging, schedule drug distribution, destruction, returns and biological services.

Cryosite (ASX:CTE) Headlines

No Headlines